MedPath

VISCOFAN SA

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells

Phase 1
Not yet recruiting
Conditions
CABG-patients
Heart Failure
Myocardial Infarction (MI)
First Posted Date
2025-05-04
Last Posted Date
2025-05-04
Lead Sponsor
Viscofan
Target Recruit Count
10
Registration Number
NCT06956807
Locations
🇵🇱

Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach, Katowice - Ochojec, Poland

First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction

Phase 1
Conditions
Heart Failure With Reduced Ejection Fraction
First Posted Date
2018-11-20
Last Posted Date
2018-11-20
Lead Sponsor
Viscofan
Target Recruit Count
10
Registration Number
NCT03746938
Locations
🇪🇸

Clínica Universidad de Navarra, Pamplona, Navarra, Spain

🇪🇸

Hospital General Universitario Gregorio Marañón, Madrid, Spain

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.